Like all medications, they may cause side effects, but when used correctly under clinical supervision, they have been shown to be safe and effective tools for managing body weight
That makes it especially relevant for patients whose weight is associated with sleep-related breathing problems
Food and Drug Administration (FDA-d)
The compounding pharmacy were working with is also working on a duplicate of Mounjaros active ingredient, tirzepatide
Serious adverse events requiring immediate medical attention include: Pancreatitis: Severe abdominal pain, sometimes radiating to the back, with or without vomiting Gallbladder disease: Right upper quadrant pain, nausea, vomiting Acute kidney injury: Decreased urine output, swelling, fatigue Thyroid C-cell tumors (boxed warning for tirzepatide): Neck mass, difficulty swallowing, persistent hoarseness Metabolic considerations include the risk of hypoglycemia, particularly in patients with type 2 diabetes taking other glucose-lowering medications